Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 1/20 | 0.50 |
| ▸ | THRB | P10828 | 1/20 | 0.50 |
| ▸ | GGPS1 | O95749 | 6/20 | 0.48 |
| ▸ | FDPS | P14324 | 9/20 | 0.41 |
| ▸ | SMPD1 | P17405 | 2/20 | 0.39 |
| ▸ | CES2 | O00748 | 1/20 | 0.39 |
| ▸ | LPAR1 | Q92633 | 1/20 | 0.39 |
| ▸ | LPAR3 | Q9UBY5 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28085782 | 1.00 | TSHR (0.50) | TSHRTHRBGGPS1FDPSSMPD1 | |
| SCHEMBL9808555 | 1.00 | TSHR (0.50) | TSHRTHRBGGPS1FDPSSMPD1 | |
| SCHEMBL7253883 | 1.00 | TSHR (0.50) | TSHRTHRBGGPS1FDPSSMPD1 | |
| SCHEMBL28857305 | 1.00 | TSHR (0.50) | TSHRTHRBGGPS1FDPSSMPD1 | |
| SCHEMBL28445910 | 0.97 | TSHR (0.47) | TSHRTHRBGGPS1FDPSSMPD1 | |
| SCHEMBL6989967 | 0.97 | TSHR (0.47) | TSHRTHRBGGPS1FDPSSMPD1 | |
| SCHEMBL27669639 | 0.97 | GGPS1 (0.44) | TSHRTHRBGGPS1FDPSSMPD1 | |
| SCHEMBL27377628 | 0.94 | GGPS1 (0.44) | TSHRTHRBGGPS1FDPSSMPD1 | |
| SCHEMBL29064055 | 0.88 | TSHR (0.44) | TSHRTHRBGGPS1FDPSSMPD1 | |
| SCHEMBL8670374 | 0.88 | TSHR (0.44) | TSHRTHRBGGPS1FDPSSMPD1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-111247141-A | Epoxy-oxetane compound, method for synthesizing same, and use of same | 四国化成工业株式会社 | 2020-06-05 | — | — | CN | disclosed |
| EP-2791099-B1 | PRODUCTION OF ACETIC ACID WITH ENHANCED CATALYST STABILITY | CELANESE INT CORP (US) | 2017-02-01 | — | — | EP | disclosed |
| US-8916727-B2 | Production of acetic acid with enhanced catalyst stability | CELANESE INTERNATIONAL CORPORATION (US) | 2014-12-23 | — | — | US | disclosed |
| EP-2791099-A1 | PRODUCTION OF ACETIC ACID WITH ENHANCED CATALYST STABILITY | Celanese International Corporation (US) | 2014-10-22 | — | — | EP | disclosed |
| US-20130184491-A1 | Production of Acetic Acid with Enhanced Catalyst Stability | CELANESE INTERNATIONAL CORPORATION (US) | 2013-07-18 | — | — | US | disclosed |
| WO-2013090720-A1 | PRODUCTION OF ACETIC ACID WITH ENHANCED CATALYST STABILITY | CELANESE INTERNATIONAL CORPORATION (US) | 2013-06-20 | — | — | WO | disclosed |
| US-5753730-A | Plastic lenses having a high-refractive index, process for the preparation thereof and casting polymerization process for preparing sulfur-containing urethane resin lens and lens prepared thereby | MITSUI TOATSU CHEMICALS, INC. (JP) | 1998-05-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130184491-A1 | Production of Acetic Acid with Enhanced Catalyst Stability | ACADM, CA6, ADH5 | TSHR 2810/4885THRB 3428/4885GGPS1 2158/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.